Advertisement

Topics

German biotech startup receives $29.4M investment to develop mRNA drugs

05:28 EDT 23 Aug 2017 | SmartBrief

AstraZeneca has invested about $29.4 million in a research alliance with Ethris, a biotech startup in Germany, to develop mes -More

Original Article: German biotech startup receives $29.4M investment to develop mRNA drugs

NEXT ARTICLE

More From BioPortfolio on "German biotech startup receives $29.4M investment to develop mRNA drugs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...